Tolis G A, Sfyras N, Astras G, Georgiou G
Department of Cardiac Surgery, Athens Medical Center, Greece.
Tex Heart Inst J. 1998;25(3):185-93.
We studied 287 consecutive patients who underwent valve replacement procedures under retrograde warm-blood cardioplegia between 1 March 1992 and 30 June 1997 (64 months). Some of the procedures were performed in combination with other operations (70), but most (217) were isolated. Thirty patients had undergone previous "open" procedures and another 25 patients had undergone prior "closed" procedures. The 30-day postoperative mortality rate was 3.8% (11 deaths). In 7 patients, the cause of death was not cardiogenic. We did not observe any instance of right ventricular failure, perforation of the coronary sinus, phrenic nerve palsy, or wound infection. These results indicate that retrograde warm-blood cardioplegia provides excellent myocardial protection of both ventricles during valve replacement.
我们研究了1992年3月1日至1997年6月30日（64个月）期间接受逆行温血心脏停搏下瓣膜置换手术的287例连续患者。部分手术与其他手术联合进行（70例），但大多数（217例）为单纯手术。30例患者曾接受过先前的“开放”手术，另有25例患者曾接受过先前的“闭合”手术。术后30天死亡率为3.8%（11例死亡）。7例患者的死亡原因并非心源性。我们未观察到右心室衰竭、冠状窦穿孔、膈神经麻痹或伤口感染的任何病例。这些结果表明，逆行温血心脏停搏在瓣膜置换期间可为双心室提供优异的心肌保护。
